Bone parameters are improved with intermittent dosing of vitamin D 3 and calcitonin

Calcified Tissue International

Volumn 83, Issue 6, 2008, Pages 393-403

  Andresen, C J ^a   Moalli, M ^a   Turner, C H ^b   Berryman, E ^a   Pero, R ^a   Bagi, C M ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Bone biomarker; Bone quality; Bone strength; Calcitonin; Ovariectomized rat; Parathyroid hormone; Vitamin D3

Indexed keywords

CALCITONIN; CALCITRIOL; COLECALCIFEROL; PARATHYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE STRENGTH; BONE STRUCTURE; CANCELLOUS BONE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICAL BONE; DRUG INTERMITTENT THERAPY; FEMALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSSIFICATION; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; RAT;

ABSORPTIOMETRY, PHOTON; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE REMODELING; CALCITONIN; CHOLECALCIFEROL; FEMALE; FEMUR; OVARY; RATS; RATS, SPRAGUE-DAWLEY; STRESS, MECHANICAL; TIBIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 57249113724     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-008-9187-5     Document Type: Article

References (50)

1. DW Dempster F Cosman M Parisien V Shen R Lindsay 1993 Anabolic actions of parathyroid hormone on bone Endocr Rev 14 690 709
2. DB Kimmel RP Bozzato KA Kronis T Coble D Sindrey P Kwong RR Recker 1993 The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats Endocrinology 132 1577 1584
3. C Crandall 2002 Parathyroid hormone for treatment of osteoporosis Arch Intern Med 16 2297 2309
4. DM Black JP Bilezikian KE Ensrud SL Greenspan L Palermo T Hue TF Lang JA McGowan CJ Rosen 2005 One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis N Engl J Med 353 555 565
5. DM Black SL Greenspan KE Ensrud L Palermo JA McGowen TF Lang P Garnero ML Bouxsein JP Bilezikian CJ Rosen 2003 The effects of parathyroid hormone and alendronate alone or in combination in postemenopausal osteoporosis N Engl J Med 25 1207 1215
6. JS Finkelstein A Hayes JL Hunzelman JJ Wyland H Lee RM Neer 2003 The effects of parathyroid hormone, alendronate, or both in men with osteoporosis N Engl J Med 25 1216 1226
7. PD Delmas P Vergnaud ME Arlot P Pastoureau PJ Meunier MH Nilssen 1995 The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate-is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone 16 603 610
8. M Li Mosekilde Li CH Søgaard JS Thomsen TJ Wronski 1995 Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats Bone 16 629 635
9. BD Baumann TJ Wronski 1995 Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats Bone 16 247 253
10. R Rizzoli S Boonen ML Brandi N Burlet P Delmas JY Reginster 2008 The role of calcium and vitamin D in the management of osteoporosis Bone 42 246 249
11. MF Holick 2006 Resurrection of vitamin D deficiency and rickets J Clin Invest 116 2062 2072
12. R Narbaitz WE Stumpf M Sar S Huang HF DeLuca 1983 Autoradiographic localization of target cells for 1α,25-dihydroxyvitamin D3 in bones from fetal rats Calcif Tissue Int 35 177 182
13. RG Erben S Bromm M Stangassinger 1998 Therapeutic efficacy of 1α,25-dihydroxyvitamin D3 and calcium in osteopenic ovariectomized rats: evidence for a direct anabolic effect of 1α,25-dihydroxyvitamin D3 on bone Endocrinology 139 4319 4328
14. M Montero-Odasso G Duque 2005 Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone Mol Aspects Med 26 203 219
15. WJ Pike 2006 New steroidal vitamin D receptor modulators: are these ligands the real deal? BoneKEy Osteovision 3 14 18
16. M Zaidi AM Inzerillo BS Moonga PJR Bevis CL-H Huang 2002 Forty years of calcitonin-where are we now? A tribute to the work of Iain Macintyre, FRS Bone 30 655 663
17. TJ Martin 1999 Calcitonin, an update Bone 24 Suppl 63S 65S
18. RA Davey HA Morris 2005 The effects of salmon calcitonin-induced hypocalcemia on bone metabolism in ovariectomized rats J Bone Miner Metab 23 359 365
19. S Wada N Udagawa N Nagata 1996 Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts Endocrinology 137 1042 1048
20. Frost HM (1983) Bone histomorphometry: analysis of trabecular bone dynamics. In: Recker R (ed) Bone histomorphometry, techniques and interpretation. CRC Press, Boca Raton, FL, pp 109-131
21. AM Parfitt FH Glorieux JA Kanis H Malluche PJ Meunier SM Ott RR Recker 1987 Bone histomorphometry nomenclature, symbols and units J Bone Miner Res 2 595 610
22. RM Francis M Peacock SA Barkworth 1984 Renal impairment and its effects on calcium metabolism in elderly women Age Aging 13 14 20
23. A Cannigia R Nuti F Lore G Martini V Turchetti G Righi 1990 Long-term treatment with calcitriol in postmenopausal osteoporosis Metabolism 39 Suppl 1 43 49
24. ME Ooms JC Roos PD Bezemer WJF Van der Vijfh LM Bouther P Lips 1995 Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial J Clin Endocrinol Metab 80 1052 1058
25. JC Gallagher CM Jerpbak WSS Jee KA Johnson HF DeLuca BL Riggs 1982 1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis Proc Natl Acad Sci USA 79 3325 3329
26. JC Gallagher BL Riggs RR Recker D Goldgar 1989 The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency Proc Soc Exp Biol Med 191 287 292
27. M Tilyard G Spears J Thomson S Dovey 1992 Treatment of postmenopausal osteoporosis with calcitriol or calcium N Engl J Med 326 357 362
28. 3 Bone Miner 20 223 234
29. 3 and calcium to prevent hip fractures in elderly women N Engl J Med 327 1637 1642
30. JL Vahle M Sato GG Long JK Young PC Francis JA Engelhardt MS Westmore Y Linda JB Nold 2002 Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety Toxicol Pathol 30 312 321
31. M Sato YL Ma JM Hock MS Westmore J Vahle A Villanueva CH Turner 2002 Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment J Pharmacol Exp Ther 302 304 313
32. MR Allen DB Burr 2007 Mineralization, microdamage, and matrix: how bisphosphonates influence material properties of bone BoneKEy Osteovision 4 49 60
33. KHW Lau D Baylink 1999 Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy Calcif Tissue Int 65 295 306
34. H Devlin G Lumb MWJ Ferguson 1992 Serum parathyroid hormone and calcitonin levels following ovariectomy in the adult rat Exp Clin Endocrinol 99 84 86
35. CH Chesnut III S Silverman K Andriano H Genant A Gimona S Harris D Kiel M LeBoff M Maricic P Miller C Moniz M Peacock P Richardson N Watts D Baylink 2000 A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study PROOF Study group. Am J Med 109 267 276
36. MT McDermott GS Kidd 1987 The role of calcitonin in the development and treatment of osteoporosis Endocr Rev 8 377 3390
37. J-J Body 2002 Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis Bone 30 75S 79S
38. JA Kanis 2002 Calcitonin in osteoporosis Bone 30 65S 66S
39. S Wallach G Roussau L Martin M Azria 1999 Effects of calcitonin on animal and in vitro models of skeletal metabolism Bone 25 509 516
40. HM Kronenberg 1997 Parathyroid hormone and osteocalcin-when friends become strangers Endocrinology 138 3083 3084
41. LG Raisz JA Wener CL Trummel 1972 Induction, inhibition and escape as phenomenon in bone resorption Excerpta Medica Int Cong Ser 243 446 453
42. HH Messer DH Copp 1974 Changes in response to calcitonin following prolonged administration to intact rats Proc Soc Exp Biol Med 146 643 647
43. K Tada T Yamamuro H Okumura R Kasai H Takahashi 1990 Restoration of axial and apendicular bone volumes by h-PTH (1-34) in parathyreoidectomized and osteopenic rats Bone 11 163 169
44. D Chappard N Retailleau-Gaborit E Legrand M Felix Basle M Audran 2005 Comparison insight bone measurements by histomorphometry and mCT J Bone Miner Res 20 1177 1184
45. MA Miller SP Bare RR Recker SY Smith J Fox 2008 Intratrabecular tunneling increases trabecular number throughout the skeleton of ovariectomized rhesus monkeys treated with parathyroid hormone 1-84 Bone 42 1175 1183
46. S Nishida A Yamaguchi T Tanizawa N Endo T Mashiba Y Uchiyama T Suda S Yoshiki HE Takahashi 1994 Increased bone formation by intermittent PTH administration is due to the simulation of proliferation and differentiation of osteoprogenitor cells in bone marrow Bone 15 717 723
47. TJ Wronski AM Ratkus JS Thomsen Q Vulcan L Mosekilde 2001 Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats J Bone Miner Res 16 1399 1407
48. A Iida-Klein C Hughes SS Lu A Moreno V Shen DW Dempster F Cosman R Lindsay 2006 Effects of cyclic versus daily hPTH (1-34) regimens on bone strength in association with BMD, biochemical markers, and bone structure in mice J Bone Miner Res 21 274 282
49. 3 in bone remodeling events Am J Immunol 2 40 51
50. HM Frost 1990 Structural adaptation to mechanical usage (SATMU). 1. Redefining Wolff's law: the bone remodeling problem Anat Rec 226 414 422